Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation studyArticle Published on 2023-09-202024-09-04 Journal: EClinicalMedicine [Category] 대상포진, [키워드] molnupiravir Nirmatrelvir-ritonavir SARS-CoV-2 viral disease [DOI] 10.1016/j.eclinm.2023.102225 PMC 바로가기 [Article Type] Article
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort studyarticle Published on 2023-07-142024-09-05 Journal: The Lancet Regional Health - Europe [Category] update2024, [키워드] COVID-19 Effectiveness molnupiravir Nirmatrelvir/ritonavir real-world SARS-CoV-2 [DOI] 10.1016/j.lanepe.2023.100684 PMC 바로가기 [Article Type] article
Molnupiravir as the COVID-19 panacea: false beliefs in low- and middle-income countriesArticle Commentary Published on 2023-07-032024-09-05 Journal: Pathogens and global health [Category] update2024, [키워드] Antiviral COVID-19 drug control drug dispense molnupiravir [DOI] 10.1080/20477724.2023.2232593 PMC 바로가기 [Article Type] Article Commentary
Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir ProphylaxisLetters to the Editor Published on 2023-06-292024-09-05 Journal: Turkish Journal of Hematology [Category] update2024, [키워드] COVID-19 hematopoietic stem cell transplantation molnupiravir SARS-CoV-2 [DOI] 10.4274/tjh.galenos.2023.2022.0526 PMC 바로가기 [Article Type] Letters to the Editor
Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virusEditorial Published on 2023-06-282024-09-05 Journal: Molecular Therapy. Nucleic Acids [Category] update2024, [키워드] error catastrophe lethal mutagenesis molnupiravir SARS-CoV-2 [DOI] 10.1016/j.omtn.2023.06.006 PMC 바로가기 [Article Type] Editorial
Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in JapanOriginal Research Published on 2023-06-122024-09-05 Journal: Advances in therapy [Category] update2024, [키워드] conjoint analysis COVID-19 ensitrelvir Intangible cost Japan molnupiravir Nirmatrelvir/ritonavir online survey oral antivirals Patient preference [DOI] 10.1007/s12325-023-02564-4 PMC 바로가기 [Article Type] Original Research
Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsReview Published on 2023-05-262024-09-05 Journal: International journal of antimicrobial agents [Category] update2024, [키워드] COVID-19 molnupiravir Randomized controlled trials SARS-CoV-2 [DOI] 10.1016/j.ijantimicag.2023.106870 PMC 바로가기 [Article Type] Review
Sustainable Stability-Indicating spectra manipulations for the concurrent quantification of a novel Anti-COVID-19 drug and its active Metabolite: Green profile assessmentArticle Published on 2023-05-242024-09-05 Journal: Spectrochimica acta. Part A, Molecular and biomole [Category] update2024, [키워드] coronavirus green molnupiravir N-hydroxycytidine stability-indicating UV- spectrophotometry [DOI] 10.1016/j.saa.2023.122911 PMC 바로가기 [Article Type] Article
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysisArticle Published on 2023-04-302024-09-05 Journal: International journal of antimicrobial agents [Category] update2024, [키워드] COVID-19 Haemodialysis molnupiravir Oral antiviral agent rapid antigen detection test SARS-CoV-2 [DOI] 10.1016/j.ijantimicag.2023.106834 PMC 바로가기 [Article Type] Article
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariantsArticle Published on 2023-04-202024-09-05 Journal: Antiviral Research [Category] update2024, [키워드] antiviral activity molnupiravir Nirmatrelvir Omicron subvariant Remdesivir SARS-CoV-2 [DOI] 10.1016/j.antiviral.2023.105609 PMC 바로가기 [Article Type] Article